ACADIA PHARMACEUTICALS INC Income Tax Expense (Benefit) in USD from 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Acadia Pharmaceuticals Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to Q3 2025.
  • Acadia Pharmaceuticals Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2025 was -$27.2M, a 550% decline year-over-year.
  • Acadia Pharmaceuticals Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2025 was $12.5M, a 52.6% increase year-over-year.
  • Acadia Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2024 was $31.6M, a 209% increase from 2023.
  • Acadia Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2023 was $10.3M, a 305% increase from 2022.
  • Acadia Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2022 was $2.53M, a 621% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)

ACADIA PHARMACEUTICALS INC Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $12.5M -$27.2M -$33.2M -550% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 $45.7M $13.5M +$9.75M +257% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $36M $8.79M +$4.35M +97.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $31.6M $17.3M +$23.4M Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 $8.19M $6.04M -$6.99M -53.6% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 $15.2M $3.79M -$1.44M -27.5% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 $16.6M $4.45M +$6.37M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 $10.3M -$6.09M -$6.93M -830% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 $17.2M $13M +$12.3M +1597% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $4.91M $5.23M +$4.79M +1080% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $128K -$1.92M -$2.4M -495% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $2.53M $835K +$646K +342% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 $1.89M $768K +$1.1M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $785K $443K -$30K -6.34% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $815K $485K +$464K +2210% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $351K $189K Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$332K -$133K -66.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $473K +$80K +20.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $21K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 -$199K +$65K +24.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $393K +$28K +7.67% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q4 2019 $876K $400K +$386K +2757% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $490K -$264K -$640K -170% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $1.13M $365K +$146K +66.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $984K $375K -$272K -42% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $1.26M $14K +$45K Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $1.21M $376K -$291K -43.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $1.5M $219K -$179K -45% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $1.68M $647K +$562K +661% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $1.12M -$31K Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $667K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $398K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $85K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04

ACADIA PHARMACEUTICALS INC Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $31.6M +$21.4M +209% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 $10.3M +$7.72M +305% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 $2.53M +$2.18M +621% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 $351K -$260K -42.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $611K -$265K -30.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $876K -$380K -30.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $1.26M +$137K +12.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $1.12M -$222K -16.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $1.34M +$1.01M +306% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $330K +$330K Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $0 $0 Jan 1, 2014 Dec 31, 2014 10-K 2015-02-26
2013 $0 $0 Jan 1, 2013 Dec 31, 2013 10-K 2015-02-26
2012 $0 -$17K -100% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-26
2011 $17K +$5K +41.7% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-27
2010 $12K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.